{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:55:12Z","timestamp":1791039312057,"version":"4.1.0"},"reference-count":326,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.pharmthera.2006.02.008","type":"journal-article","created":{"date-parts":[[2006,4,18]],"date-time":"2006-04-18T19:18:47Z","timestamp":1145387927000},"page":"949-973","source":"Crossref","is-referenced-by-count":122,"title":["Inactivating mutations of G protein-coupled receptors and diseases: Structure-function insights and therapeutic implications"],"prefix":"10.1016","volume":"111","author":[{"given":"Ya-Xiong","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2006.02.008_bib1","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1006\/bbrc.2000.3291","article-title":"Functional analysis of five endothelin-B receptor mutations found in human Hirschsprung disease patients","volume":"275","author":"Abe","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib2","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1172\/JCI119497","article-title":"Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland","volume":"99","author":"Abramowicz","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib3","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1210\/jc.80.9.2594","article-title":"Familial hypocalciuric hypercalcemia associated with mutation in the human Ca2+-sensing receptor gene","volume":"80","author":"Aida","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0092-8674(95)90275-9","article-title":"Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure","volume":"82","author":"Aittomaki","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib5","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1210\/jc.81.10.3722","article-title":"Clinical features of primary ovarian failure caused by a point mutation in the follicle stimulating hormone receptor gene","volume":"81","author":"Aittomaki","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib6","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1681\/ASN.V9101861","article-title":"Functional studies of twelve mutant V2 vasopressin receptors related to nephrogenic diabetes insipidus: molecular basis of a mild clinical phenotype","volume":"9","author":"Ala","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1677\/joe.1.06213","article-title":"Naturally-occurring missense mutations in the human growth hormone-releasing hormone receptor alter ligand binding","volume":"186","author":"Alba","year":"2005","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1210\/jc.87.6.2549","article-title":"Germline mutations of TSH receptor gene as cause of nonautoimmune subclinical hypothyroidism","volume":"87","author":"Alberti","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib9","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1126\/science.272.5270.1955","article-title":"CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1","volume":"272","author":"Alkhatib","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/humrep\/deg046","article-title":"A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics","volume":"18","author":"Allen","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/hmg\/5.3.355","article-title":"Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease","volume":"5","author":"Amiel","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/er.23.2.141","article-title":"The lutropin\/choriogonadotropin receptor, a 2002 perspective","volume":"23","author":"Ascoli","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib13","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/hmg\/4.12.2407","article-title":"Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease","volume":"4","author":"Attie","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/hmg\/5.3.351","article-title":"Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population","volume":"5","author":"Auricchio","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib15","doi-asserted-by":"crossref","first-page":"19537","DOI":"10.1074\/jbc.271.32.19537","article-title":"Expression and characterization of inactivating and activating mutations in the human Cao2+-sensing receptor","volume":"271","author":"Bai","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1172\/JCI119137","article-title":"In vivo and in vitro characterization of neonatal hyperparathyroidism resulting from a de novo, heterozygous mutation in the Ca2+-sensing receptor gene: normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia","volume":"99","author":"Bai","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.011303698","article-title":"Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus","volume":"98","author":"Barak","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1172\/JCI7866","article-title":"Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice","volume":"104","author":"Barton-Davis","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib19","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1086\/319500","article-title":"Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair","volume":"68","author":"Bastiaens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib20","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1172\/JCI3795","article-title":"A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor","volume":"102","author":"Beau","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib21","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1093\/hmg\/ddi219","article-title":"Altered cell surface expression of human MC1R variant receptor alleles associated with red hair and skin cancer risk","volume":"14","author":"Beaumont","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0303-7207(03)00201-6","article-title":"Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function","volume":"205","author":"Bedecarrats","year":"2003","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib23","doi-asserted-by":"crossref","first-page":"30603","DOI":"10.1074\/jbc.272.49.30603","article-title":"Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5\u03b432","volume":"272","author":"Benkirane","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib24","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1210\/jc.86.4.1580","article-title":"Prevalence, phenotypic spectrum, and modes of inheritance of gonadotropin-releasing hormone receptor mutations in idiopathic hypogonadotropic hypogonadism","volume":"86","author":"Beranova","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib26","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.fertnstert.2005.04.029","article-title":"The prevalence of gonadotropin-releasing hormone receptor mutations in a large cohort of patients with hypogonadotropic hypogonadism","volume":"84","author":"Bhagavath","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib27","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1210\/jc.82.10.3471","article-title":"Mutations of the human thyrotropin receptor gene causing thyroid hypoplasia and persistent congenital hypothyroidism","volume":"82","author":"Biebermann","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib28","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.2337\/diabetes.52.12.2984","article-title":"Autosomal-dominant mode of inheritance of a melanocortin-4 receptor mutation in a patient with severe early-onset obesity is due to a dominant-negative effect caused by receptor dimerization","volume":"52","author":"Biebermann","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib29","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1210\/me.8.7.886","article-title":"An extracellular congenital nephrogenic diabetes insipidus mutation of the vasopressin receptor reduces cell surface expression, affinity for ligand, and coupling to the Gs\/adenylyl cyclase system","volume":"8","author":"Birnbaumer","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib30","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1182\/blood.V96.5.1638","article-title":"Multiple nonfunctional alleles of CCR5 are frequent in various human populations","volume":"96","author":"Blanpain","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib31","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/10606820212135","article-title":"CCR5 and HIV infection","volume":"8","author":"Blanpain","year":"2002","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/emboj\/18.7.1723","article-title":"Molecular tinkering of G protein-coupled receptors: an evolutionary success","volume":"18","author":"Bockaert","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib33","doi-asserted-by":"crossref","first-page":"20203","DOI":"10.1074\/jbc.M301319200","article-title":"Structural and functional role of helices I and II in rhodopsin. A novel interplay evidenced by mutations at Gly-51 and Gly-89 in the transmembrane domain","volume":"278","author":"Bosch","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib34","doi-asserted-by":"crossref","first-page":"882","DOI":"10.2337\/diabetes.46.5.882","article-title":"Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in Caucasian sib pairs with a history of diabetic nephropathy","volume":"46","author":"Bowden","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib35","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1093\/hmg\/6.11.1891","article-title":"Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair","volume":"6","author":"Box","year":"1997","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib36","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1210\/jc.2003-031047","article-title":"Unexpected effects of epitope and chimeric tags on gonadotropin-releasing hormone receptors: implications for understanding the molecular etiology of hypogonadotropic hypogonadism","volume":"88","author":"Brothers","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1379\/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2","article-title":"Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein","volume":"1","author":"Brown","year":"1996","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib38","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1210\/en.141.9.3518","article-title":"A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse","volume":"141","author":"Butler","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib39","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1093\/hmg\/ddi329","article-title":"Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance","volume":"14","author":"Calebiro","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1365-2265.2005.02314.x","article-title":"Thyrotropin receptor gene mutations and TSH resistance: variable expressivity in the heterozygotes","volume":"63","author":"Camilot","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/eje.0.1480025","article-title":"A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency","volume":"148","author":"Carakushansky","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib42","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.85.5.2042","article-title":"Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor","volume":"85","author":"Carling","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib43","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1210\/jc.84.3.990","article-title":"Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration","volume":"84","author":"Caron","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib44","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/301645","article-title":"Novel alleles of the chemokine-receptor gene CCR5","volume":"61","author":"Carrington","year":"1997","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib45","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1093\/hmg\/4.11.2089","article-title":"Interstitial deletion of the endothelin-B receptor gene in the spotting lethal (sl) rat","volume":"4","author":"Ceccherini","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib46","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2265.2003.01696.x","article-title":"Two Italian kindreds with familial hypocalciuric hypercalcaemia caused by loss-of-function mutations in the calcium-sensing receptor (CaR) gene: functional characterization of a novel CaR missense mutation","volume":"58","author":"Cetani","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/79254","article-title":"Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass","volume":"26","author":"Chen","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0014-5793(92)80820-7","article-title":"Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA","volume":"309","author":"Chhajlani","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib49","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1046\/j.1365-2265.1999.00729.x","article-title":"An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor","volume":"50","author":"Chikatsu","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib50","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0092-8674(00)81313-6","article-title":"The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates","volume":"85","author":"Choe","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib51","first-page":"1075","article-title":"Mutations in the human Ca2+-sensing-receptor gene that cause familial hypocalciuric hypercalcemia","volume":"56","author":"Chou","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI200421136","article-title":"Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes","volume":"114","author":"Chuang","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0140-6736(93)90208-X","article-title":"Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor","volume":"341","author":"Clark","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1210\/er.19.6.828","article-title":"Adrenocorticotropin insensitivity syndromes","volume":"19","author":"Clark","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.tem.2005.10.006","article-title":"Inherited ACTH insensitivity illuminates the mechanisms of ACTH action","volume":"16","author":"Clark","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib56","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1210\/jc.82.4.1094","article-title":"Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH","volume":"82","author":"Clifton-Bligh","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib57","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1073\/pnas.92.7.3070","article-title":"Defective intracellular transport is the molecular basis of rhodopsin- dependent dominant retinal degeneration","volume":"92","author":"Colley","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib58","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1038\/nn1455","article-title":"Anatomy and regulation of the central melanocortin system","volume":"8","author":"Cone","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib59","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1210\/jc.86.6.2680","article-title":"Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction","volume":"86","author":"Costa","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib60","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1089\/thy.1999.9.995","article-title":"Structure-function relationships of two loss-of-function mutations of the thyrotropin receptor gene","volume":"9","author":"Costagliola","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/humu.1212","article-title":"An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"18","author":"D'Souza-Li","year":"2001","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib62","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.87.3.1309","article-title":"Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia","volume":"87","author":"D'Souza-Li","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib63","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1210\/jc.81.12.4229","article-title":"Four families with loss of function mutations of the thyrotropin receptor","volume":"81","author":"de Roux","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib64","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJM199711273372205","article-title":"A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor","volume":"337","author":"de Roux","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib65","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/jc.84.2.567","article-title":"The same molecular defects of the gonadotropin-releasing hormone receptor determine a variable degree of hypogonadism in affected kindred","volume":"84","author":"de Roux","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/381661a0","article-title":"Identification of a major co-receptor for primary isolates of HIV-1","volume":"381","author":"Deng","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib67","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/358761a0","article-title":"Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive","volume":"358","author":"Denning","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib68","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1210\/jc.87.3.1151","article-title":"A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure","volume":"87","author":"Doherty","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib69","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1210\/jc.2003-030903","article-title":"Deletion of codons 88-92 of the melanocortin-4 receptor gene: a novel deleterious mutation in an obese female","volume":"88","author":"Donohoue","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib70","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0092-8674(00)81314-8","article-title":"A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors","volume":"85","author":"Doranz","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib71","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/343364a0","article-title":"A point mutation of the rhodopsin gene in one form of retinitis pigmentosa","volume":"343","author":"Dryja","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib72","first-page":"3124","article-title":"Novel rhodopsin mutations Gly114Val and Gln184Pro in dominant retinitis pigmentosa","volume":"41","author":"Dryja","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib73","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1067\/mpd.2001.116284","article-title":"Mutational analysis of melanocortin-4 receptor, agouti-related protein, and \u03b1-melanocyte-stimulating hormone genes in severely obese children","volume":"139","author":"Dubern","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddi001","article-title":"Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes","volume":"14","author":"Duchatelet","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib75","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/j.cellsig.2005.05.020","article-title":"The regulatory mechanisms of export trafficking of G protein-coupled receptors","volume":"17","author":"Duvernay","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib76","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1210\/jc.84.8.2766","article-title":"Functional characterization of naturally occurring mutations of the human adrenocorticotropin receptor: poor correlation of phenotype and genotype","volume":"84","author":"Elias","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib77","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2265.2000.01122.x","article-title":"Tall stature in familial glucocorticoid deficiency","volume":"53","author":"Elias","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib78","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","article-title":"Role of melanocortinergic neurons in feeding and the agouti obesity syndrome","volume":"385","author":"Fan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib79","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/humu.9150","article-title":"Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean population","volume":"21","author":"Fargnoli","year":"2003","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib80","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI9397","article-title":"Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency","volume":"106","author":"Farooqi","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib81","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib82","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/emboj\/21.5.857","article-title":"On the genetics of retinitis pigmentosa and on mutation-independent approaches to therapeutic intervention","volume":"21","author":"Farrar","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2004-830523","article-title":"Identification of a novel calcium-sensing receptor gene mutation causing familial hypocalciuric hypercalcemia by single-strand conformation polymorphism analysis","volume":"113","author":"Felderbauer","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib84","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2337\/diabetes.54.9.2663","article-title":"Co-occurrence of two partially inactivating polymorphisms of MC3R is associated with pediatric-onset obesity","volume":"54","author":"Feng","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib85","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1210\/jc.2002-020501","article-title":"Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay","volume":"87","author":"Fluck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib86","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1006\/bbrc.1998.8459","article-title":"Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor","volume":"245","author":"Frandberg","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1126\/science.2218504","article-title":"Rhodopsin mutants that bind but fail to activate transducin","volume":"250","author":"Franke","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib88","doi-asserted-by":"crossref","first-page":"14767","DOI":"10.1016\/S0021-9258(18)42106-0","article-title":"Structure and function in rhodopsin. Studies of the interaction between the rhodopsin cytoplasmic domain and transducin","volume":"267","author":"Franke","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib89","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF03401945","article-title":"Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirschsprung's disease: evidence for selective loss of Gi coupling","volume":"7","author":"Fuchs","year":"2001","journal-title":"Mol Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib90","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1210\/jc.83.5.1771","article-title":"Apparent congenital athyreosis contrasting with normal plasma thyroglobulin levels and associated with inactivating mutations in the thyrotropin receptor gene: are athyreosis and ectopic thyroid distinct entities?","volume":"83","author":"Gagne","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib91","doi-asserted-by":"crossref","first-page":"8246","DOI":"10.1016\/S0021-9258(18)53088-X","article-title":"Molecular cloning of a novel melanocortin receptor","volume":"268","author":"Gantz","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib92","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1073\/pnas.93.2.867","article-title":"Null mutation of endothelin receptor type B gene in spotting lethal rats causes aganglionic megacolon and white coat color","volume":"93","author":"Gariepy","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib93","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1210\/en.140.11.5066","article-title":"The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH","volume":"140","author":"Gaylinn","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib94","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1210\/er.21.1.90","article-title":"Uncovering molecular mechanisms involved in activation of G protein-coupled receptors","volume":"21","author":"Gether","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib95","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1073\/pnas.96.5.2198","article-title":"Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish affected sib pairs","volume":"96","author":"Ghosh","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib96","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/ng0793-227","article-title":"GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function","volume":"4","author":"Godfrey","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib97","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/ng1197-273","article-title":"Overexpression of Agrt leads to obesity in transgenic mice","volume":"17","author":"Graham","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib98","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0303-7207(96)03949-4","article-title":"Functional and clinical consequences of mutations in the FSH receptor","volume":"125","author":"Gromoll","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib99","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.85.6.2281","article-title":"Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH","volume":"85","author":"Gromoll","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib100","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/eje.0.1470597","article-title":"Homozygous mutation within the conserved Ala-Phe-Asn-Glu-Thr motif of exon 7 of the LH receptor causes male pseudohermaphroditism","volume":"147","author":"Gromoll","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib101","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.136.7.3146","article-title":"The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt\/hyt mouse results in plasma membrane targeting but defective TSH binding","volume":"136","author":"Gu","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib102","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2337\/diabetes.48.3.635","article-title":"Identification and functional analysis of novel human melanocortin-4 receptor variants","volume":"48","author":"Gu","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib103","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1210\/jc.86.6.2895","article-title":"Naturally occurring mutations in the melanocortin receptor 3 gene are not associated with type 2 diabetes mellitus in French Caucasians","volume":"86","author":"Hani","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib104","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1086\/302863","article-title":"Evidence for variable selective pressures at MC1R","volume":"66","author":"Harding","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib105","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1210\/jc.81.4.1312","article-title":"Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains","volume":"81","author":"Health","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib106","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1210\/jc.84.4.1483","article-title":"Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans","volume":"84","author":"Hinney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib107","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1210\/jc.2003-030233","article-title":"Melanocortin-4 receptor gene: case-control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity","volume":"88","author":"Hinney","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib108","doi-asserted-by":"crossref","first-page":"35816","DOI":"10.1074\/jbc.274.50.35816","article-title":"Functional characterization of mutations in melanocortin-4 receptor associated with human obesity","volume":"274","author":"Ho","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib109","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1146\/annurev.ge.24.120190.001025","article-title":"The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein","volume":"24","author":"Hobbs","year":"1990","journal-title":"Annu Rev Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib110","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1210\/endo-123-3-1355","article-title":"Identification of a protein in adrenal particulates that binds adrenocorticotropin specifically and with high affinity","volume":"123","author":"Hofmann","year":"1988","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib111","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/0092-8674(94)90017-5","article-title":"Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice","volume":"79","author":"Hosoda","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib112","doi-asserted-by":"crossref","first-page":"16228","DOI":"10.1074\/jbc.274.23.16228","article-title":"Naturally occurring CCR5 extracellular and transmembrane domain variants affect HIV-1 Co-receptor and ligand binding function","volume":"274","author":"Howard","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib113","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1043-2760(03)00104-8","article-title":"Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function","volume":"14","author":"Hu","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib114","doi-asserted-by":"crossref","first-page":"30023","DOI":"10.1074\/jbc.270.50.30023","article-title":"Identification of two amino acid residues on the extracellular domain of the lutropin\/choriogonadotropin receptor important in signaling","volume":"270","author":"Huang","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib115","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib116","doi-asserted-by":"crossref","first-page":"10571","DOI":"10.1073\/pnas.94.20.10571","article-title":"Structure and function in rhodopsin: packing of the helices in the transmembrane domain and folding to a tertiary structure in the intradiscal domain are coupled","volume":"94","author":"Hwa","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib117","doi-asserted-by":"crossref","first-page":"34150","DOI":"10.1074\/jbc.M204955200","article-title":"A rhodopsin mutant linked to autosomal dominant retinitis pigmentosa is prone to aggregate and interacts with the ubiquitin proteasome system","volume":"277","author":"Illing","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib118","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1021\/bi991981z","article-title":"W276 mutation in the endothelin receptor subtype B impairs Gq coupling but not Gi or Go coupling","volume":"39","author":"Imamura","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib119","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1046\/j.1365-2265.2000.01040.x","article-title":"Novel mutations of the ACTH receptor gene in a female adult patient with adrenal unresponsiveness to ACTH","volume":"53","author":"Ishii","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib120","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1210\/jc.2002-020568","article-title":"Melanocortin 4 receptor sequence variations are seldom a cause of human obesity: the Swedish Obese Subjects, the HERITAGE Family Study, and a Memphis cohort","volume":"87","author":"Jacobson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib121","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1182\/blood-2005-03-1307","article-title":"Aminoglycoside suppression of nonsense mutations in severe hemophilia","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib122","first-page":"880","article-title":"Insertion of an Alu sequence in the Ca(2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"56","author":"Janicic","year":"1995","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib123","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1210\/jc.87.7.3255","article-title":"Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target","volume":"87","author":"Janovick","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib124","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1126\/science.3008329","article-title":"Receptor-associated resistance to growth hormone-releasing factor in dwarf \u201clittle\u201d mice","volume":"232","author":"Jansson","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/en.138.1.85","article-title":"Temperature sensitivity of some mutants of the lutropin\/choriogonadotropin receptor","volume":"138","author":"Jaquette","year":"1997","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib126","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/diabetes.46.5.876","article-title":"New susceptibility locus for NIDDM is localized to human chromosome 20q","volume":"46","author":"Ji","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib127","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0014-5793(01)03025-3","article-title":"Thr40 and Met122 are new partial loss-of-function natural mutations of the human melanocortin 1 receptor","volume":"508","author":"Jimenez-Cervantes","year":"2001","journal-title":"FEBS Lett"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1046\/j.0022-202x.2001.01393.x","article-title":"The Pro162 variant is a loss-of-function mutation of the human melanocortin 1 receptor gene","volume":"117","author":"Jimenez-Cervantes","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1172\/JCI2918","article-title":"Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia","volume":"102","author":"Jobert","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib130","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/humu.9030","article-title":"Four novel variants in MC1R in red-haired South African individuals of European descent: S83P, Y152X, A171D, P256S","volume":"19","author":"John","year":"2002","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib131","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1749-6632.2003.tb03193.x","article-title":"DNA polymorphism and selection at the melanocortin-1 receptor gene in normally pigmented southern African individuals","volume":"994","author":"John","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib132","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1210\/en.139.12.5255","article-title":"Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia","volume":"139","author":"Karaplis","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib133","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1210\/jc.2002-020005","article-title":"Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism","volume":"88","author":"Karges","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib134","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1210\/jc.84.10.3713","article-title":"A frame-shift mutation in the type I parathyroid hormone (PTH)\/PTH-related peptide receptor causing Blomstrand lethal osteochondrodysplasia","volume":"84","author":"Karperien","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib135","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1021\/bi00186a011","article-title":"Structure and function in rhodopsin: 7. Point mutations associated with autosomal dominant retinitis pigmentosa","volume":"33","author":"Kaushal","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib136","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.domaniend.2003.12.001","article-title":"Functional and phylogenetic analyses of a melanocortin-4 receptor mutation in domestic pigs","volume":"26","author":"Kim","year":"2004","journal-title":"Domest Anim Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib137","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1210\/jc.82.8.2716","article-title":"Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism","volume":"82","author":"Kobayashi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib138","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2337\/diabetes.51.1.243","article-title":"A novel homozygous missense mutation of melanocortin-4 receptor (MC4R) in a Japanese woman with severe obesity","volume":"51","author":"Kobayashi","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib139","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/PL00000941","article-title":"The TSH receptor and its role in thyroid disease","volume":"58","author":"Kopp","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib140","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1210\/jc.85.9.3002","article-title":"A new compound heterozygous mutation of the gonadotropin-releasing hormone receptor (L314X, Q106R) in a woman with complete hypogonadotropic hypogonadism: chronic estrogen administration amplifies the gonadotropin defect","volume":"85","author":"Kottler","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib141","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ng0295-160","article-title":"Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene","volume":"9","author":"Kremer","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib142","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1128\/JVI.75.18.8449-8460.2001","article-title":"Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution","volume":"75","author":"Kuhmann","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib143","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ng0297-201","article-title":"Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility","volume":"15","author":"Kumar","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib144","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/hmg\/5.3.347","article-title":"Novel mutations of the endothelin-B receptor gene in isolated patients with Hirschsprung's disease","volume":"5","author":"Kusafuka","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib145","doi-asserted-by":"crossref","first-page":"15676","DOI":"10.1073\/pnas.0405155101","article-title":"Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons","volume":"101","author":"Lai","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib146","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cccn.2005.04.026","article-title":"Novel missense mutation in the CASR gene in a Chinese family with familial hypocalciuric hypercalcemia","volume":"360","author":"Lam","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib147","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1210\/jc.2004-0497","article-title":"Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity","volume":"90","author":"Larsen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib148","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJM199602223340805","article-title":"Testicular and ovarian resistance to luteinizing hormone caused by homozygous inactivating mutations of the luteinizing hormone receptor gene","volume":"334","author":"Latronico","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib149","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1210\/me.12.3.442","article-title":"A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expresssion and impaired effector activation by the cell surface receptor","volume":"12","author":"Latronico","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib150","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/hmg\/4.8.1429","article-title":"A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia","volume":"4","author":"Laue","year":"1995","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib151","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1210\/me.10.8.987","article-title":"Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia","volume":"10","author":"Laue","year":"1996","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib152","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S0015-0282(97)00480-9","article-title":"The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure","volume":"69","author":"Layman","year":"1998","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib153","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ng0198-14","article-title":"Mutations in gonadotropin-releasing hormone receptor gene cause hypogonadotropic hypogonadism","volume":"18","author":"Layman","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib154","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1210\/jc.2002-020961","article-title":"Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism","volume":"87","author":"Leanos-Miranda","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib155","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1210\/jc.87.3.1423","article-title":"A novel melanocortin 3 receptor gene (MC3R) mutation associated with severe obesity","volume":"87","author":"Lee","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib156","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1073\/pnas.65.3.745","article-title":"ACTH receptors in the adrenal: specific binding of ACTH-125I and its relation to adenyl cyclase","volume":"65","author":"Lefkowitz","year":"1970","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib157","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI119637","article-title":"Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q","volume":"100","author":"Lembertas","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib158","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ajmg.a.20681","article-title":"A novel missense homozygous inactivating mutation in the fourth transmembrane helix of the luteinizing hormone receptor in leydig cell hypoplasia","volume":"130","author":"Leung","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib159","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1073\/pnas.95.20.11933","article-title":"Effect of vitamin A supplementation on rhodopsin mutants threonine-17 \u2192 methionine and proline-347 \u2192 serine in transgenic mice and in cell cultures","volume":"95","author":"Li","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib160","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.ijo.0801114","article-title":"Melanocortin 3 receptor (MC3R) gene variants in extremely obese women","volume":"24","author":"Li","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib161","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/364208a0","article-title":"Molecular basis of the little mouse phenotype and implications for cell type-specific growth","volume":"364","author":"Lin","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib162","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"Liu","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib163","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-0854.2003.00097.x","article-title":"Endoplasmic reticulum retention, degradation, and aggregation of olfactory G-protein coupled receptors","volume":"4","author":"Lu","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib164","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/ddg016","article-title":"Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations","volume":"12","author":"Lubrano-Berthelier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib165","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1210\/jc.2003-031993","article-title":"A homozygous null mutation delineates the role of the melanocortin-4 receptor in humans","volume":"89","author":"Lubrano-Berthelier","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib166","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.2337\/diabetes.53.10.2696","article-title":"Melanocortin 4 receptor gene variation is associated with severe obesity in Pima Indians","volume":"53","author":"Ma","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib167","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.peptides.2005.03.064","article-title":"Obesity-associated mutations in the human melanocortin-4 receptor gene","volume":"27","author":"Mackenzie","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib168","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1210\/jc.2003-030739","article-title":"Familial hypocalciuric hypercalcemia in a woman with metastatic breast cancer: a case report of mistaken identity","volume":"88","author":"Marcocci","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib169","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/me.12.6.775","article-title":"A homozygous mutation of the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype","volume":"12","author":"Martens","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib170","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.87.6.2506","article-title":"Mutant luteinizing hormone receptors in a compound heterozygous patient with complete Leydig cell hypoplasia: abnormal processing causes signaling deficiency","volume":"87","author":"Martens","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib171","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.ijo.0802244","article-title":"A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish population","volume":"27","author":"Marti","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib172","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1136\/jmg.2003.011536","article-title":"Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure","volume":"41","author":"Matichard","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib173","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00335-001-3038-2","article-title":"A mouse model of Waardenburg syndrome type 4 with a new spontaneous mutation of the endothelin-B receptor gene","volume":"13","author":"Matsushima","year":"2002","journal-title":"Mamm Genome"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib174","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1210\/jc.87.5.2144","article-title":"Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site","volume":"87","author":"Maya-Nunez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib175","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1210\/jc.2003-030217","article-title":"Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies","volume":"88","author":"Meduri","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib176","series-title":"The Endocrine Society's 86th Annual Meeting","first-page":"140","article-title":"Identification of three novel melanocortin 3 receptor (MC3R) gene mutations in patients with morbid obesity","author":"Mencarelli","year":"2004"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib177","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molmed.2005.02.007","article-title":"Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy","volume":"11","author":"Mendes","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib178","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1210\/jc.86.7.3448","article-title":"A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity","volume":"86","author":"Mergen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib179","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s003359900790","article-title":"A missense mutation in the endothelin-B receptor gene is associated with Lethal White Foal Syndrome: an equine version of Hirschsprung disease","volume":"9","author":"Metallinos","year":"1998","journal-title":"Mamm Genome"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib180","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1210\/jc.2003-031808","article-title":"GNRHR mutations in a woman with idiopathic hypogonadotropic hypogonadism highlight the differential sensitivity of luteinizing hormone and follicle-stimulating hormone to gonadotropin-releasing hormone","volume":"89","author":"Meysing","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib181","doi-asserted-by":"crossref","first-page":"9400","DOI":"10.1016\/S0021-9258(18)98364-X","article-title":"Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation","volume":"268","author":"Min","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib182","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.ijo.0801983","article-title":"Low frequency of melanocortin-4 receptor (MC4R) mutations in a Mediterranean population with early-onset obesity","volume":"26","author":"Miraglia Del Giudice","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib183","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1210\/jc.82.7.2159","article-title":"Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor","volume":"82","author":"Misrahi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib184","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/j.1365-2265.2004.02163.x","article-title":"Identification and functional analysis of a novel inactivating mutation (A804D) of the calcium-sensing receptor gene","volume":"61","author":"Miyashiro","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib185","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1210\/me.2003-0406","article-title":"Intracellularly located misfolded glycoprotein hormone receptors associate with different chaperone proteins than their cognate wild-type receptors","volume":"18","author":"Mizrachi","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib186","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib187","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib188","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib189","doi-asserted-by":"crossref","first-page":"6766","DOI":"10.1021\/bi002699r","article-title":"Association of calnexin with wild type and mutant AVPR2 that causes nephrogenic diabetes insipidus","volume":"40","author":"Morello","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib190","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2002-021946","article-title":"Absence of exon 10 of the human luteinizing hormone (LH) receptor impairs LH, but not human chorionic gonadotropin action","volume":"88","author":"Muller","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib191","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1089\/105072501750302859","article-title":"Novel inactivating missense mutations in the thyrotropin receptor gene in Japanese children with resistance to thyrotropin","volume":"11","author":"Nagashima","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib192","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1210\/jc.81.4.1442","article-title":"Demonstration by transfection studies that mutations in the adrenocorticotropin receptor gene are one cause of the hereditary syndrome of glucocorticoid deficiency","volume":"81","author":"Naville","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib193","doi-asserted-by":"crossref","first-page":"22939","DOI":"10.1074\/jbc.M211326200","article-title":"Poor cell surface expression of human melanocortin-4 receptor mutations associated with obesity","volume":"278","author":"Nijenhuis","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib194","doi-asserted-by":"crossref","first-page":"14442","DOI":"10.1074\/jbc.M300087200","article-title":"Pharmacological chaperone-mediated in vivo folding and stabilization of the P23H-opsin mutant associated with autosomal dominant retinitis pigmentosa","volume":"278","author":"Noorwez","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib195","doi-asserted-by":"crossref","first-page":"16278","DOI":"10.1074\/jbc.M312101200","article-title":"Retinoids assist the cellular folding of the autosomal dominant retinitis pigmentosa opsin mutant P23H","volume":"279","author":"Noorwez","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib196","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1126\/science.278.5335.135","article-title":"Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein","volume":"278","author":"Ollmann","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib197","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0960-9822(00)00386-9","article-title":"G-protein-coupled receptors function as oligomers in vivo","volume":"10","author":"Overton","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib198","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0960-9822(07)00378-8","article-title":"Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus","volume":"8","author":"Palacios","year":"1998","journal-title":"Curr Biol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib199","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1126\/science.289.5480.739","article-title":"Crystal structure of rhodopsin: A G protein-coupled receptor","volume":"289","author":"Palczewski","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib200","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/302711","article-title":"Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?","volume":"66","author":"Palmer","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib201","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/ng1092-103","article-title":"Mutations in the V2 vasopressin receptor gene are associated with X- linked nephrogenic diabetes insipidus","volume":"2","author":"Pan","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib202","doi-asserted-by":"crossref","first-page":"31933","DOI":"10.1016\/S0021-9258(18)31785-X","article-title":"The effect of eight V2 vasopressin receptor mutations on stimulation of adenylyl cyclase and binding to vasopressin","volume":"269","author":"Pan","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib203","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/humu.9253","article-title":"Novel MC1R variants in Ligurian melanoma patients and controls","volume":"24","author":"Pastorino","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib204","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1172\/JCI118335","article-title":"Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism","volume":"96","author":"Pearce","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib205","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1172\/JCI118987","article-title":"Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells","volume":"98","author":"Pearce","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib206","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1046\/j.1365-2265.1996.750891.x","article-title":"Calcium-sensing receptor mutations in familial hypocalciuric hypercalcaemia with recurrent pancreatitis","volume":"45","author":"Pearce","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib207","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.cr.7290070","article-title":"Melanocortin-1 receptor gene variants in four Chinese ethnic populations","volume":"11","author":"Peng","year":"2001","journal-title":"Cell Res"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib208","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/07435800009048569","article-title":"Functional expression of the human ACTH receptor gene","volume":"26","author":"Penhoat","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib209","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1074\/jbc.M007151200","article-title":"Newly synthesized human delta opioid receptors retained in the endoplasmic reticulum are retrotranslocated to the cytosol, deglycosylated, ubiquitinated, and degraded by the proteasome","volume":"276","author":"Petaja-Repo","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib210","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/hmg\/ddi176","article-title":"Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia","volume":"14","author":"Pidasheva","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib211","doi-asserted-by":"crossref","first-page":"12784","DOI":"10.1016\/S0021-9258(18)99944-8","article-title":"Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator","volume":"269","author":"Pind","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib212","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/0092-8674(93)90617-Y","article-title":"Mutations in the human Ca2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism","volume":"75","author":"Pollak","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib213","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib214","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1210\/jc.84.10.3811","article-title":"Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor","volume":"84","author":"Pralong","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib215","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/0092-8674(94)90016-7","article-title":"A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease","volume":"79","author":"Puffenberger","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib216","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.bbadis.2004.03.009","article-title":"Inactivation and intracellular retention of the human I183N mutated melanocortin 3 receptor associated with obesity","volume":"1689","author":"Rached","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib217","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1128\/JVI.71.4.3219-3227.1997","article-title":"Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation","volume":"71","author":"Rana","year":"1997","journal-title":"J Virol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib218","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/genetics\/151.4.1547","article-title":"High polymorphism at the human melanocortin 1 receptor locus","volume":"151","author":"Rana","year":"1999","journal-title":"Genetics"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib219","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.pharmtox.41.1.593","article-title":"Genetic variations and polymorphisms of G protein-coupled receptors: functional and therapeutic implications","volume":"41","author":"Rana","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib220","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/molehr\/8.4.311","article-title":"Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation","volume":"8","author":"Rannikko","year":"2002","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib221","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1210\/er.19.6.673","article-title":"The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies","volume":"19","author":"Rapoport","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib222","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1046\/j.0300-0664.2001.01437.x","article-title":"Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene","volume":"56","author":"Richter-Unruh","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib223","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1530\/eje.1.01852","article-title":"Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis","volume":"152","author":"Richter-Unruh","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib224","doi-asserted-by":"crossref","first-page":"F265","DOI":"10.1152\/ajprenal.00404.2004","article-title":"Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model","volume":"289","author":"Robben","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib225","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1091\/mbc.E05-06-0579","article-title":"Rescue of vasopressin v2 receptor mutants by chemical chaperones: specificity and mechanism","volume":"17","author":"Robben","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib226","doi-asserted-by":"crossref","first-page":"42198","DOI":"10.1074\/jbc.M510180200","article-title":"Mechanisms of cell-surface rerouting of an endoplasmic reticulum-retained mutant of the vasopressin V1b\/V3 receptor by a pharmacological chaperone","volume":"280","author":"Robert","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib227","unstructured":"Rong, R., Tao, Y. X., Xu, A., Cheung, B. M. Y., Cheung, G., & Lam, K. S. L. (in press). Identification and characterization of three novel missense mutations of the human melanocortin-4 receptor gene in a Chinese obesity population. Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.pharmthera.2006.02.008_bib228","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.90.19.8856","article-title":"Identification of a receptor for \u03b3 melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system","volume":"90","author":"Roselli-Rehfuss","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib229","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/359233a0","article-title":"Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus","volume":"359","author":"Rosenthal","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib230","doi-asserted-by":"crossref","first-page":"13030","DOI":"10.1016\/S0021-9258(19)38614-4","article-title":"Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase","volume":"268","author":"Rosenthal","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib231","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrfmmm.2004.09.014","article-title":"MC1R and the response of melanocytes to ultraviolet radiation","volume":"571","author":"Rouzaud","year":"2005","journal-title":"Mutat Res"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib232","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1210\/en.139.4.1588","article-title":"Association of gonadotropin receptor precursors with the protein folding chaperone calnexin","volume":"139","author":"Rozell","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib233","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1210\/jc.85.11.4238","article-title":"A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH","volume":"85","author":"Russo","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib234","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1208\/ps030322","article-title":"Genetic variations in human G protein-coupled receptors: implications for drug therapy","volume":"3","author":"Sadee","year":"2001","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib235","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1210\/me.11.12.1806","article-title":"Biochemical basis of partial nephrogenic diabetes insipidus phenotypes","volume":"11","author":"Sadeghi","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib236","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.mce.2004.09.005","article-title":"Leydig cell hypoplasia due to inactivation of luteinizing hormone receptor by a novel homozygous nonsense truncation mutation in the seventh transmembrane domain","volume":"229","author":"Salameh","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib237","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1242\/jcs.115.14.2907","article-title":"The cellular fate of mutant rhodopsin: quality control, degradation and aggresome formation","volume":"115","author":"Saliba","year":"2002","journal-title":"J Cell Sci"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib238","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1210\/jc.86.1.273","article-title":"Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type ib","volume":"86","author":"Salvatori","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib239","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2265.2001.01273.x","article-title":"Isolated growth hormone (GH) deficiency due to compound heterozygosity for two new mutations in the GH-releasing hormone receptor gene","volume":"54","author":"Salvatori","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib240","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/382722a0","article-title":"Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene","volume":"382","author":"Samson","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib241","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1046\/j.1432-1033.2002.03329.x","article-title":"Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function","volume":"269","author":"Sanchez Mas","year":"2002","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib242","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s00383-005-1553-z","article-title":"Novel mutation of Endothelin-B receptor gene in Waardenburg-Hirschsprung disease","volume":"21","author":"Sangkhathat","year":"2005","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib243","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/hmg\/ddh105","article-title":"Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo","volume":"13","author":"Sangkuhl","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib244","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1210\/jc.2003-031175","article-title":"Genetic screening for melanocortin-4 receptor mutations in a cohort of italian obese patients: description and functional characterization of a novel mutation","volume":"89","author":"Santini","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib245","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1074\/jbc.271.2.635","article-title":"Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation","volume":"271","author":"Sato","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib246","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.ijo.0802184","article-title":"Melanocortin-3-receptor gene variants in morbid obesity","volume":"27","author":"Schalin-Jantti","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib247","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jcp.1041630119","article-title":"Adrenocorticotropin-resistant mutants of the Y1 adrenal cell line fail to express the adrenocorticotropin receptor","volume":"163","author":"Schimmer","year":"1995","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib248","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1006\/bbrc.1999.0935","article-title":"Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair","volume":"260","author":"Schioth","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib249","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/(SICI)1098-1004(1998)12:3<196::AID-HUMU7>3.0.CO;2-F","article-title":"V2 vasopressin receptor dysfunction in nephrogenic diabetes insipidus caused by different molecular mechanisms","volume":"12","author":"Schoneberg","year":"1998","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib250","first-page":"143","article-title":"The structural basis of G-protein-coupled receptor function and dysfunction in human diseases","volume":"144","author":"Schoneberg","year":"2002","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib251","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pharmthera.2004.08.008","article-title":"Mutant G-protein-coupled receptors as a cause of human diseases","volume":"104","author":"Schoneberg","year":"2004","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib252","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/mol.54.3.525","article-title":"A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS. M6 cells","volume":"54","author":"Schulein","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib253","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1210\/jc.2002-020286","article-title":"Aminoglycoside pretreatment partially restores the function of truncated V(2) vasopressin receptors found in patients with nephrogenic diabetes insipidus","volume":"87","author":"Schulz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib254","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/bjo.2004.063933","article-title":"Novel rhodopsin mutations and genotype-phenotype correlation in patients with autosomal dominant retinitis pigmentosa","volume":"89","author":"Schuster","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib255","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0950-351X(95)80519-2","article-title":"G protein-coupled receptor structure and function: the impact of disease-causing mutations","volume":"9","author":"Shenker","year":"1995","journal-title":"Bailliere's Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib256","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1210\/jc.87.6.2973","article-title":"Novel homozygous splice acceptor site GnRH receptor (GnRHR) mutation: human GnRHR \u201cknockout\u201d","volume":"87","author":"Silveira","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib257","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/er.18.6.739","article-title":"The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology","volume":"18","author":"Simoni","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib258","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-2265.2001.01211.x","article-title":"A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene","volume":"54","author":"Soderlund","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib259","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1146\/annurev.ph.58.030196.001043","article-title":"Defects in G protein-coupled signal transduction in human disease","volume":"58","author":"Spiegel","year":"1996","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev.med.55.091902.103843","article-title":"Inherited diseases involving G proteins and G protein-coupled receptors","volume":"55","author":"Spiegel","year":"2004","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib261","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1172\/JCI116680","article-title":"Abnormalities in G protein-coupled signal transduction pathways in human disease","volume":"92","author":"Spiegel","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib262","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1210\/jc.83.6.2091","article-title":"A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters","volume":"83","author":"Stavrou","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib263","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1210\/me.8.2.129","article-title":"Identification of a point mutation in the thyrotropin receptor of the hyt\/hyt hypothyroid mouse","volume":"8","author":"Stein","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib264","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/10606820212137","article-title":"Rhodopsin and retinitis pigmentosa: shedding light on structure and function","volume":"8","author":"Stojanovic","year":"2002","journal-title":"Receptors Channels"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib265","doi-asserted-by":"crossref","first-page":"39020","DOI":"10.1074\/jbc.M303625200","article-title":"Retinitis pigmentosa rhodopsin mutations L125R and A164V perturb critical interhelical interactions: new insights through compensatory mutations and crystal structure analysis","volume":"278","author":"Stojanovic","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib266","doi-asserted-by":"crossref","first-page":"26645","DOI":"10.1016\/S0021-9258(19)74360-9","article-title":"Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa. Clustering of functional classes along the polypeptide chain","volume":"268","author":"Sung","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib267","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1073\/pnas.88.19.8840","article-title":"Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa","volume":"88","author":"Sung","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib268","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1056\/NEJM199501193320305","article-title":"Resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene","volume":"332","author":"Sunthornthepvarakul","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib269","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1034\/j.1399-0004.1999.550312.x","article-title":"Mutations in the endothelin-receptor B gene in Hirschsprung disease in Sweden","volume":"55","author":"Svensson","year":"1999","journal-title":"Clin Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.0.CO;2-R","article-title":"Novel nonsense mutation of the endothelin-B receptor gene in a family with Waardenburg-Hirschsprung disease","volume":"87","author":"Syrris","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib271","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1182\/blood.V97.11.3651","article-title":"A homologous naturally occurring mutation in Duffy and CCR5 leading to reduced receptor expression","volume":"97","author":"Tamasauskas","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib272","doi-asserted-by":"crossref","first-page":"11378","DOI":"10.1074\/jbc.273.18.11378","article-title":"Novel mutations of the endothelin B receptor gene in patients with Hirschsprung's disease and their characterization","volume":"273","author":"Tanaka","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib273","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2005.04.012","article-title":"Molecular mechanisms of the neural melanocortin receptor dysfunction in severe early-onset obesity","volume":"239","author":"Tao","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib274","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1210\/en.2003-0524","article-title":"Functional characterization of melanocortin-4 receptor mutations associated with childhood obesity","volume":"144","author":"Tao","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib275","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1210\/jc.2004-0367","article-title":"Functional characterization of melanocortin-3 receptor variants identify a loss-of-function mutation involving an amino acid critical for G protein-coupled receptor activation","volume":"89","author":"Tao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib276","doi-asserted-by":"crossref","first-page":"5632","DOI":"10.1210\/jc.2005-0519","article-title":"Functional analyses of melanocortin-4 receptor mutations identified from patients with binge eating disorder and nonobese or obese subjects","volume":"90","author":"Tao","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib277","doi-asserted-by":"crossref","first-page":"5904","DOI":"10.1074\/jbc.M311162200","article-title":"Constitutive and agonist-dependent self-association of the cell surface human lutropin receptor","volume":"279","author":"Tao","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib278","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/ng0297-205","article-title":"Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility","volume":"15","author":"Tapanainen","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib279","doi-asserted-by":"crossref","first-page":"14817","DOI":"10.1074\/jbc.272.23.14817","article-title":"Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A","volume":"272","author":"Tarasova","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib280","doi-asserted-by":"crossref","first-page":"48666","DOI":"10.1074\/jbc.M309941200","article-title":"Mutationally induced disulfide bond formation within the third extracellular loop causes melanocortin 4 receptor inactivation in patients with obesity","volume":"278","author":"Tarnow","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib281","first-page":"R248","article-title":"Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion","volume":"274","author":"Thiele","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib282","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/thy.1999.9.887","article-title":"The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor","volume":"9","author":"Tiosano","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib283","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1210\/jc.81.11.3850","article-title":"An inactivating mutation of the luteinizing hormone receptor causes amenorrhea in a 46,XX female","volume":"81","author":"Toledo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib284","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1210\/jc.85.3.1001","article-title":"Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene","volume":"85","author":"Tonacchera","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib285","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1210\/jc.2004-1243","article-title":"Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism","volume":"89","author":"Tonacchera","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib286","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/me.13.11.1844","article-title":"New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype","volume":"13","author":"Touraine","year":"1999","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib287","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1172\/JCI116853","article-title":"Hereditary isolated glucocorticoid deficiency is associated with abnormalities of the adrenocorticotropin receptor gene [see comments]","volume":"92","author":"Tsigos","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib288","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1210\/jc.80.7.2186","article-title":"A novel mutation of the adrenocorticotropin receptor (ACTH-R) gene in a family with the syndrome of isolated glucocorticoid deficiency, but no ACTH-R abnormalities in two families with the triple A syndrome","volume":"80","author":"Tsigos","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib289","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1172\/JCI118252","article-title":"Binding-, intracellular transport-, and biosynthesis-defective mutants of vasopressin type 2 receptor in patients with X-linked nephrogenic diabetes insipidus","volume":"96","author":"Tsukaguchi","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib290","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/2407","article-title":"A frameshift mutation in human MC4R is associated with a dominant form of obesity","volume":"20","author":"Vaisse","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib291","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity","volume":"106","author":"Vaisse","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib292","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/jc.2003-031182","article-title":"Identification and characterization of melanocortin-4 receptor gene mutations in morbidly obese Finnish children and adults","volume":"89","author":"Valli-Jaakola","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib293","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/ng1195-328","article-title":"Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans","volume":"11","author":"Valverde","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib294","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1093\/hmg\/5.10.1663","article-title":"The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma","volume":"5","author":"Valverde","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib295","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ng1092-99","article-title":"Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus","volume":"2","author":"van den Ouweland","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib296","doi-asserted-by":"crossref","first-page":"15935","DOI":"10.1074\/jbc.M211546200","article-title":"Cell surface expression of the melanocortin-4 receptor is dependent on a C-terminal di-isoleucine sequence at codons 316\/317","volume":"278","author":"VanLeeuwen","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib297","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1046\/j.1365-2265.2000.01042.x","article-title":"A new missense mutation in the calcium-sensing receptor in familial benign hypercalcaemia associated with partial lipoatrophy and insulin resistant diabetes","volume":"53","author":"Vigouroux","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib298","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/me.6.3.394","article-title":"Studies on the role of amino acids 38-45 in the expression of a functional thyrotropin receptor","volume":"6","author":"Wadsworth","year":"1992","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib299","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ng0196-88","article-title":"Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse","volume":"12","author":"Wajnrajch","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib300","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/(SICI)1098-1004(1997)10:3<233::AID-HUMU9>3.0.CO;2-J","article-title":"A novel mutation (L174R) in the Ca2+-sensing receptor gene associated with familial hypocalciuric hypercalcemia","volume":"10","author":"Ward","year":"1997","journal-title":"Hum Mutat"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib301","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1210\/jc.2003-031653","article-title":"Functional deletion of the calcium-sensing receptor in a case of neonatal severe hyperparathyroidism","volume":"89","author":"Ward","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib302","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/hmg\/3.4.585","article-title":"Mutations of the ACTH receptor gene are only one cause of familial glucocorticoid deficiency","volume":"3","author":"Weber","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib303","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1210\/jc.80.1.65","article-title":"Adrenocorticotropin receptor gene mutations in familial glucocorticoid deficiency: relationships with clinical features in four families","volume":"80","author":"Weber","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib304","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/0092-8674(93)90353-R","article-title":"Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis","volume":"73","author":"Welsh","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib305","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(96)03926-3","article-title":"Functional characterization of five V2 vasopressin receptor gene mutations","volume":"124","author":"Wenkert","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib306","doi-asserted-by":"crossref","first-page":"11981","DOI":"10.1021\/bi020275m","article-title":"Apparent loss-of-function mutant GPCRs revealed as constitutively desensitized receptors","volume":"41","author":"Wilbanks","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib307","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"Wilschanski","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib308","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0015-0282(02)04667-8","article-title":"A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene","volume":"79","author":"Wolczynski","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib309","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1093\/hmg\/ddi131","article-title":"A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels","volume":"14","author":"Wolstencroft","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-8227(02)00126-2","article-title":"Melanocortin-3 receptor gene variants in a Maori kindred with obesity and early onset type 2 diabetes","volume":"58","author":"Wong","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib311","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","article-title":"CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro","volume":"185","author":"Wu","year":"1997","journal-title":"J Exp Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib312","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1210\/me.12.11.1651","article-title":"Inactivation of the luteinizing hormone\/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia","volume":"12","author":"Wu","year":"1998","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib313","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1006\/mgme.1998.2724","article-title":"Genetic heterogeneity of adrenocorticotropin (ACTH) resistance syndromes: identification of a novel mutation of the ACTH receptor gene in hereditary glucocorticoid deficiency","volume":"64","author":"Wu","year":"1998","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib314","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1210\/jc.86.4.1788","article-title":"Absence of functional type 1 parathyroid hormone (PTH)\/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction","volume":"86","author":"Wysolmerski","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib315","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1210\/jc.2004-1791","article-title":"Functional characterization of calcium-sensing receptor codon 227 mutations presenting as either familial (benign) hypocalciuric hypercalcemia or neonatal hyperparathyroidism","volume":"90","author":"Wystrychowski","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib316","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1359\/jbmr.2002.17.12.2174","article-title":"Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene","volume":"17","author":"Yamauchi","year":"2002","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib317","doi-asserted-by":"crossref","first-page":"23000","DOI":"10.1074\/jbc.272.37.23000","article-title":"Molecular basis for the interaction of [Nle4,D-Phe7]melanocyte stimulating hormone with the human melanocortin-1 receptor","volume":"272","author":"Yang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib318","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1210\/me.11.3.274","article-title":"Effects of recombinant agouti-signaling protein on melanocortin action","volume":"11","author":"Yang","year":"1997","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib319","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1093\/hmg\/7.6.1047","article-title":"A dinucleotide mutation in the endothelin-B receptor gene is associated with lethal white foal syndrome (LWFS); a horse variant of Hirschsprung disease","volume":"7","author":"Yang","year":"1998","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib320","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/12506","article-title":"Obesity in the mouse model of pro-opiomelanocortin deficiency responds to peripheral melanocortin","volume":"5","author":"Yaswen","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib321","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/2404","article-title":"A frameshift mutation in MC4R associated with dominantly inherited human obesity","volume":"20","author":"Yeo","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib322","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/hmg\/ddg057","article-title":"Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanisms","volume":"12","author":"Yeo","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib323","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0303-7207(98)00108-7","article-title":"The unique exon 10 of the human luteinizing hormone receptor is necessary for expression of the receptor protein at the plasma membrane in the human luteinizing hormone receptor, but deleterious when inserted into the human follicle-stimulating hormone receptor","volume":"142","author":"Zhang","year":"1998","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib324","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.83.9.3373","article-title":"A homozygous inactivating mutation in the parathyroid hormone\/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia","volume":"83","author":"Zhang","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib325","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1096\/fj.05-3851com","article-title":"Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin","volume":"19","author":"Zhang","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2006.02.008_bib326","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/hmg\/6.9.1401","article-title":"A susceptibility locus for early-onset non-insulin dependent (type 2) diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene","volume":"6","author":"Zouali","year":"1997","journal-title":"Hum Mol Genet"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725806000283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725806000283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T18:45:35Z","timestamp":1627238735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725806000283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":326,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0163725806000283"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2006.02.008","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}